/
Our expectations, beliefs, estimates and projections are expressed in good faith and we believe there is a reasonable basis for them. These principal risks, uncertainties and other important factors are discussed more fully under Item 1A.
$99.67
+$4.82 (+5.08%)
Live · 05:19 PM
The institution is unprofitable. This typically signals severe credit losses or a business in transition.
Revenue growth slowed to 3.0%, essentially flat. This is a business that needs a catalyst.
Traditional FCF and operating-margin metrics are not meaningful for financial institutions. Evaluate using net interest margin, credit quality, and capital ratios instead.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$490M
▲ +3.0% YoY
Net Income (TTM)
-$12.17B
▼ -229.8% YoY
Net Margin
-2482.01%
P/E
—
Balance Sheet
Total Assets
$54.27B
Equity
$36.65B
Total Debt
$8.26B
Cash & Equiv.
$2.21B
5Y CAGR: -0.1%
Continue Research
Strategy (MSTR)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Strategy scores 40/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Strategy scores 40 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a -2,853.1% operating margin and a -20.7% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh MSTR's valuation and scores 40/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.